Due to intensive speculations about the reason for the downregulation of CD19 on tumor cells, an additional reason might be the low dissociation of FMC63 from CD19, causing a clonal selection by immune pressure of CD19-down-regulated tumor cells. This evidence concerns the gene CD19 and neoplasm.